csl must be taking so much market share. is why they do so much research spending to almost try hide the enormously profitable market position they inhabit.
News: CSL CSL's Privigen Granted Orphan-Drug Designation For The Investigational Treatment Of..., page-2
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$279.48 |
Change
-0.080(0.03%) |
Mkt cap ! $135.0B | |||
| Open | High | Low | Value | Volume |
| $279.74 | $281.78 | $278.67 | $61.02M | 217.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $279.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $279.51 | 43 | 6 |
View Market Depth
| Last trade - 14.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$279.39 |
Change
-0.080 ( 0.01 %) |
||||
| Open | High | Low | Volume | ||
| $279.64 | $281.76 | $278.68 | 63929 | ||
| Last updated 14.31pm 08/05/2024 ? | |||||
| CSL (ASX) Chart |